Stock listing

ALT Stock Price, News, Filings & Events — Altimmune, Inc.

Selected listing: ALT · BOATS · USD · US

This page tracks Altimmune, Inc.'s ALT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALT:BOATS. ALT:BOATS is the stock-level entry point for investors researching Altimmune, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Altimmune, Inc. is a public company traded under the ticker ALT in the American market. The company has a market capitalization of approximately $538.7 million. Altimmune focuses on developing innovative therapies to address unmet medical needs.

ALT:BOATSUSDUSUpdated August 28, 2026
Altimmune, Inc. logo
Ticker
ALT:BOATS
Asset type
Stock
Market cap
$605.0M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Altimmune, Inc. ALT:BOATS stock context

This page tracks Altimmune, Inc.'s ALT:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALT:BOATS. ALT:BOATS is the stock-level entry point for investors researching Altimmune, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Altimmune, Inc. is a public company traded under the ticker ALT in the American market. The company has a market capitalization of approximately $538.7 million. Altimmune focuses on developing innovative therapies to address unmet medical needs.

Latest news from Altimmune, Inc.

All Altimmune, Inc. news →

Altimmune, Inc. earnings calls

Research Altimmune, Inc.

Alternate listings